ImportRefusal LogoImportRefusal

ALLERGAN INC

⚠️ Moderate Risk

FEI: 3012333132 • Markham, ON • CANADA

FEI

FEI Number

3012333132

📍

Location

Markham, ON

🇨🇦

Country

CANADA
🏢

Address

85 Enterprise Blvd Ste, , Markham, ON, Canada

Moderate Risk

FDA Import Risk Assessment

41.0
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

3
Total Refusals
4
Unique Violations
10/4/2021
Latest Refusal
4/4/2017
Earliest Refusal

Score Breakdown

Violation Severity
84.0×40%
Refusal Volume
22.3×30%
Recency
0.0×20%
Frequency
6.7×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

752×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

161×

DIRECTIONS

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.

2371×

NO PMA

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the device appears to be a Class III device and does not appear to have in effect an approved application for premarket approval pursuant to Section 515 of the Act, or an exemption pursuant to Section 520(g)(1).

711×

NO LICENSE

The article is subject to refusal of admission under section 801(a)(3) of the Federal Food, Drug, and Cosmetic Act (FD&C Act) because it appears to be a biological product for which a biologics license is not in effect under the Public Health Service Act, Part F, Subpart 1-Biological Products, Section 351(a), and it is not the subject of an Investigational New Drug application that is in effect. Therefore, it appears to be a new drug under 201(p) of the FD&C Act that it is in violation of section 505(a) of the FD&C Act because it lacks a new drug approval and because it is misbranded under section 502(f)(1)of the FD&C Act because it fails to bear adequate directions for use

Refusal History

DateProductViolationsDivision
10/4/2021
65QCY02BOTOX
237NO PMA
Division of Southeast Imports (DSEI)
3/19/2019
61NCA99ANTI-DEPRESSANT N.E.C.
75UNAPPROVED
Division of Southeast Imports (DSEI)
4/4/2017
65QCY02BOTOX
16DIRECTIONS
71NO LICENSE
75UNAPPROVED
New Orleans District Office (NOL-DO)

Frequently Asked Questions

What is ALLERGAN INC's FDA import refusal history?

ALLERGAN INC (FEI: 3012333132) has 3 FDA import refusal record(s) in our database, spanning from 4/4/2017 to 10/4/2021.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. ALLERGAN INC's FEI number is 3012333132.

What types of violations has ALLERGAN INC received?

ALLERGAN INC has been cited for 4 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about ALLERGAN INC come from?

All FDA import refusal data for ALLERGAN INC is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.